首页 | 本学科首页   官方微博 | 高级检索  
     

奈达铂+5-Fu联合调强适形放疗治疗中晚期宫颈癌的临床观察
引用本文:李素芳,唐爽. 奈达铂+5-Fu联合调强适形放疗治疗中晚期宫颈癌的临床观察[J]. 中国现代医生, 2013, 51(26): 66-68
作者姓名:李素芳  唐爽
作者单位:广西科技大学第二附属医院放疗科,广西柳州,545005
摘    要:目的 观察奈达铂+5-Fu联合调强适形放疗治疗中晚期宫颈癌的疗效与安全性.方法 选择我院2006年3月~2008年3月46例经病理确诊的中晚期宫颈癌患者,在调强适形放疗基础上结合奈达铂+5-Fu联合化疗,本组患者为观察组,同时选择同期调强适形放疗的46例中晚期宫颈癌患者作为对照组,对患者近期疗效、不良反应进行观察,所有患者均随访6~60个月,比较远期疗效.结果 观察组总有效率89.13%;对照组总有效率63.04%;观察组近期疗效明显好于对照组,观察组1年、3年、5年生存率分别是100.0%、80.43%、65.22%;3年、5年生存率明显大于对照组,差异具有显著性(P<0.05).两组毒副反应发生率差异无显著性(P>0.05).结论 奈达铂+5-Fu联合调强适形放疗治疗中晚期宫颈癌无论是近期效果还是远期疗效,均好于单纯放疗,而且毒副反应未见高于对照组,具有较高的安全性.

关 键 词:奈达铂  5-Fu  调强适形放疗  中晚期宫颈癌  疗效  安全性

Clinical observation on nedaplatin and 5-Fu combined with intensity modulated conformal radiotherapy in the treatment of middle and ad- vanced cervical cancer
LI Sufang , TANG Shuang. Clinical observation on nedaplatin and 5-Fu combined with intensity modulated conformal radiotherapy in the treatment of middle and ad- vanced cervical cancer[J]. , 2013, 51(26): 66-68
Authors:LI Sufang    TANG Shuang
Affiliation:Department of Radiotherapy, the Second Affiliated Hospital of Guangxi University of Science and Technology, Li- uzhou 545005, China
Abstract:Objective To observe the clinical effect and security of nedaplatin and 5-Fu combined with intensity modulated conformal radiotherapy in the treatment of middle and advanced cervical cancer. Methods A total of 46 cases with middle and advanced cervical cancer from our hospital in March, 2006-March, 2008 were observation group,they were given nedaplatin and 5-Fu combined with Intensity modulated conformal radiotherapy, 46 patients with middle and advanced cervical cancer in the same period of intensity modulated conformal radiotherapy were control group. Observed the short-term curative effect and adverse reaction. All patients were followed up for 6 to 60 months, compared the long-term curative effect of two groups. Results The total effective rate of observation group was 89.13%; the total effective rate of control group was 63.04%; the short-term curative effect of observation group was better than control group,1-year,3-year,5-year survival rate of observation group were 100.0% ,80.43% ,65.22% ;3- year and 5-year survival rate of observation group were greater than control group,difference had statistics meaning(P 〈0.05).The incidence of adverse reaction of two groups had no significant differences (P 〉 0.05). Conclusions The short-term and long-term curative effect of nedaplatin and 5-Fu combined with intensity modulated conformal radiotherapy in the treatment of middle and advanced cervical cancer are better than radiotherapy,adverse reaction is not higher than control group, it has high security.
Keywords:Nedaplatin  5-Fu  Intensity modulated conformal radiotherapy  Middle and advanced cervical cancer  Curative effect  Security
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号